Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Witko SE"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Clarke DK; Department of Virology and Vaccine Development, Profectus BioSciences, Pearl River, NY, USA. Electronic address: dclarke@profectusbiosciences.com., Xu R; Department of Immunology, Profectus BioSciences, Pearl River, NY, USA., Matassov D; Department of Virology and Vaccine Development, Profectus BioSciences, Pearl River, NY, USA., Latham TE; Department of Virology and Vaccine Development, Profectus BioSciences, Pearl River, NY, USA., Ota-Setlik A; Department of Immunology, Profectus BioSciences, Pearl River, NY, USA., Gerardi CS; Department of Virology and Vaccine Development, Profectus BioSciences, Pearl River, NY, USA., Luckay A; Department of Immunology, Profectus BioSciences, Pearl River, NY, USA., Witko SE; Department of Virology and Vaccine Development, Profectus BioSciences, Pearl River, NY, USA., Hermida L; Department of Virology and Vaccine Development, Profectus BioSciences, Pearl River, NY, USA., Higgins T; Department of Virology and Vaccine Development, Profectus BioSciences, Pearl River, NY, USA., Tremblay M; Department of Quality Assurance, Profectus BioSciences, Pearl River, NY, USA., Sciotto-Brown S; Department of Regulatory Affairs, Profectus BioSciences, Pearl River, NY, USA., Chen T; Department of Virology and Vaccine Development, Profectus BioSciences, Pearl River, NY, USA., Egan MA; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA., Rusnak JM; Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical, Fort Detrick, MD, USA., Ward LA; Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical, Fort Detrick, MD, USA., Eldridge JH; Department of Virology and Vaccine Development, Profectus BioSciences, Pearl River, NY, USA; Department of Immunology, Profectus BioSciences, Pearl River, NY, USA.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Apr; Vol. 20 (4), pp. 455-466. Date of Electronic Publication: 2020 Jan 14.
Autor:
Cross RW; Galveston National Laboratory and.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Xu R; Department of Immunology., Matassov D; Department of Viral Vaccine Development, and., Hamm S; Department of Viral Vaccine Discovery, Profectus BioSciences Inc., Pearl River, New York, USA., Latham TE; Department of Viral Vaccine Development, and., Gerardi CS; Department of Viral Vaccine Development, and., Nowak RM; Department of Viral Vaccine Discovery, Profectus BioSciences Inc., Pearl River, New York, USA., Geisbert JB; Galveston National Laboratory and.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Ota-Setlik A; Department of Immunology., Agans KN; Galveston National Laboratory and.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Luckay A; Department of Immunology., Witko SE; Department of Viral Vaccine Development, and., Soukieh L; Department of Immunology., Deer DJ; Galveston National Laboratory and.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Mire CE; Galveston National Laboratory and.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Feldmann H; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, Montana, USA., Happi C; Department of Biological Sciences and African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Edo, Nigeria., Fenton KA; Galveston National Laboratory and.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Eldridge JH; Department of Immunology.; Department of Viral Vaccine Development, and.; Department of Viral Vaccine Discovery, Profectus BioSciences Inc., Pearl River, New York, USA., Geisbert TW; Galveston National Laboratory and.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2020 Jan 02; Vol. 130 (1), pp. 539-551.
Autor:
Clarke DK; Profectus Biosciences, Tarrytown, New York, USA DClarke@profectusbiosciences.net., Nasar F; University of Texas Medical Branch, Galveston, Texas, USA., Chong S; Pfizer Pharmaceuticals, Pearl River, New York, USA., Johnson JE; Pfizer Pharmaceuticals, Pearl River, New York, USA., Coleman JW; The International AIDS Vaccine Initiative, AIDS Vaccine Design and Development Laboratory, Brooklyn, New York, USA., Lee M; Pfizer Pharmaceuticals, Pearl River, New York, USA., Witko SE; Pfizer Pharmaceuticals, Pearl River, New York, USA., Kotash CS; Pfizer Pharmaceuticals, Pearl River, New York, USA., Abdullah R; Pfizer Pharmaceuticals, Pearl River, New York, USA., Megati S; Pfizer Pharmaceuticals, Pearl River, New York, USA., Luckay A; Pfizer Pharmaceuticals, Pearl River, New York, USA., Nowak B; Profectus Biosciences, Tarrytown, New York, USA., Lackner A; Tulane National Primate Research Center, Tulane University, New Orleans, Louisiana, USA., Price RE; Veterinary Pathology Services, Houston, Texas, USA., Little P; EPL Inc., Research Triangle Park, North Carolina, USA., Kalyan N; Pfizer Pharmaceuticals, Pearl River, New York, USA., Randolf V; Pfizer Pharmaceuticals, Pearl River, New York, USA., Javadian A; Pfizer Pharmaceuticals, Pearl River, New York, USA., Zamb TJ; Pfizer Pharmaceuticals, Pearl River, New York, USA., Parks CL; The International AIDS Vaccine Initiative, AIDS Vaccine Design and Development Laboratory, Brooklyn, New York, USA., Egan MA; Profectus Biosciences, Tarrytown, New York, USA., Eldridge J; Profectus Biosciences, Tarrytown, New York, USA., Hendry M; Laboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV, Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Udem SA; Pfizer Pharmaceuticals, Pearl River, New York, USA.
Publikováno v:
Journal of virology [J Virol] 2014 Jun; Vol. 88 (12), pp. 6690-701. Date of Electronic Publication: 2014 Apr 02.
Autor:
Eyles JE; Pfizer Vaccine Research, La Jolla, California, USA. jimeyles@pfizer.com, Johnson JE, Megati S, Roopchand V, Cockle PJ, Weeratna R, Makinen S, Brown TP, Lang S, Witko SE, Kotash CS, Li J, West K, Maldonado O, Falconer DJ, Lees C, Smith GJ, White P, Wright P, Loudon PT, Merson JR, Jansen KU, Sidhu MK
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2013 Jul 15; Vol. 208 (2), pp. 319-29. Date of Electronic Publication: 2013 Apr 17.
Autor:
Donald RGK; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Flint M; Centers for Disease Control, 1600 Clifton Rd, Atlanta, GA 30333, USA., Kalyan N; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Johnson E; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Witko SE; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Kotash C; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Zhao P; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Megati S; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Yurgelonis I; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Lee PK; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Matsuka YV; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Severina E; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Deatly A; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Sidhu M; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Jansen KU; Pfizer Vaccine Research, Pearl River, NY 10654, USA., Minton NP; Clostridia Research Group, NIHR Biomedical Research Unit in GI Disease, University Park, University of Nottingham, Nottingham NG7 2RD, UK., Anderson AS; Pfizer Vaccine Research, Pearl River, NY 10654, USA.
Publikováno v:
Microbiology (Reading, England) [Microbiology (Reading)] 2013 Jul; Vol. 159 (Pt 7), pp. 1254-1266. Date of Electronic Publication: 2013 Apr 29.
Autor:
Johnson JE; Pfizer Vaccine Research, 401 North Middletown Road, Pearl River, NY 10965, USA. erik.johnson@pfizer.com, McNeil LK, Megati S, Witko SE, Roopchand VS, Obregon JH, Illenberger DM, Kotash CS, Nowak RM, Braunstein E, Yurgelonis I, Jansen KU, Kalyan NK, Sidhu MK
Publikováno v:
Immunology letters [Immunol Lett] 2013 Feb; Vol. 150 (1-2), pp. 134-44. Date of Electronic Publication: 2012 Dec 20.
Autor:
Witko SE; Pfizer Vaccine Research, 401 North Middletown Road, Pearl River, NY 10965, United States., Johnson JE, Kalyan NK, Felber BK, Pavlakis GN, Sidhu MK, Hendry RM, Udem SA, Parks CL
Publikováno v:
Journal of virological methods [J Virol Methods] 2010 Mar; Vol. 164 (1-2), pp. 43-50. Date of Electronic Publication: 2009 Nov 24.
Autor:
Witko SE; Wyeth Vaccines Research, 401 North Middletown Road, Pearl River, NY 10965, USA., Kotash CS, Nowak RM, Johnson JE, Boutilier LA, Melville KJ, Heron SG, Clarke DK, Abramovitz AS, Hendry RM, Sidhu MS, Udem SA, Parks CL
Publikováno v:
Journal of virological methods [J Virol Methods] 2006 Jul; Vol. 135 (1), pp. 91-101. Date of Electronic Publication: 2006 Mar 29.